Efficacy of a Novel Antibacterial Agent Exeporfinium Chloride, (XF-73), Against Antibiotic-Resistant Bacteria in Mouse Superficial Skin Infection Models
Chenrui Zhang,Jinping Li,Rong Lu,Song Wang,Zheng Fu,Zhi Yao
DOI: https://doi.org/10.2147/IDR.S417231
2023-07-26
Infection and Drug Resistance
Abstract:Chenrui Zhang, 1 Jinping Li, 2 Rong Lu, 2 Song Wang, 2 Zheng Fu, 2 Zhi Yao 1 1 Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China; 2 Kangzhe Pharmaceutical Technology Development Company, Ltd., Tianjin, People's Republic of China Correspondence: Zhi Yao, Tianjin Medical University, Tianjin, 300070, People's Republic of China, Tel/Fax +8622-83336817, Email Zheng Fu, Kangzhe Pharmaceutical Technology Development Company, Tianjin, 300110, People's Republic of China, Tel/Fax +86 13821232027, Email Background: The number of incidences of antimicrobial resistance is rising continually, necessitating new and effective antibacterial drugs. The present study aimed to assess the in vitro and in vivo activity of XF-73 against antibiotic-resistant Staphylococcus aureus ( S. aureus ) isolates and to investigate the potential mechanism of action of XF-73. Methods: The in vitro antibacterial activity of XF-73 and comparator antibacterial drugs, (mupirocin, fusidine, retapamulin, vancomycin, erythromycin, linezolid and daptomycin), against S. aureus (both antibiotic sensitive and resistant strains) was assessed using a broth microdilution method. Two different superficial Staphylococcal skin infection murine models were established to study the in vivo efficacy of XF-73 against antibiotic-resistant strains. The effect of XF-73 on the ultrastructure and cellular morphology of S. aureus was studied using transmission electron microscopy (TEM) and scanning electron microscopy (SEM). Results: The MICs (minimum inhibitory concentration) determined by the broth microdilution method for XF-73 demonstrated that the compound had a high potency against S. aureus isolates with varying susceptibility to the study drugs. Also, the antibacterial activity of XF-73 was superior or similar to most of the tested antibacterial drugs. We also found that the XF-73 dermal formulation significantly inhibited S. aureus survival in both the murine skin tape-stripping and suture superficial skin infection models, maintained a consistently high inhibitory capacity against the antibiotic-resistant strains tested and was significantly more effective than mupirocin ointment, a commonly used antibiotic for the treatment of skin infections. The morphological studies using TEM suggest that XF-73 had a rapid (2 minute) bacterial cell wall disruption activity, with longer incubation (10 minute) subsequently causing membrane damage. SEM analysis demonstrated that this cell wall and cell membrane disruption did not lead to disintegration of the plasma membrane, and did not cause bacterial cell lysis. Conclusion: Therefore, XF-73 may be an effective drug alternative to combat multi-drug-resistant skin infections in the clinical setting. Keywords: antibiotic resistance, mupirocin-resistant strains, skin infections, bacterial cell membrane, in vivo, S. aureus Skin and soft tissue infections (SSTIs) are some of the most common bacterial infections. Many bacteria and fungi species reside on the surface of human skin which are usually prevented from entering the body by the intact skin barrier and do not pose a threat of infection. However, in the case of skin damage, bacteria may invade the skin and subcutaneous tissue to cause infection. SSTIs are mainly caused by Gram-positive bacteria, especially S. aureus . In addition, SSTIs are clinical conditions that vary in severity, etiology, and presentation. They include microbial invasion of the skin and underlying soft tissues and range in severity from relatively minor to extremely serious, ie, fatal infections. 1 Infections limited to the skin and underlying superficial soft tissue are termed simple infections; for example, cellulitis, impetigo, and trauma-associated infections. A simple infection is characterized by the absence of systemic symptoms that indicate the spread of infection and the absence of complications that could make treatment challenging. For simple infections, topical antimicrobials, such as the topical antibiotics mupirocin and fusidic acid, are optimal. 2 In vitro studies have demonstrated that mupirocin exhibits good antimicrobial activity against Gram-positive cocci such as S. aureus, Staphylococcus epidermidis , and other β-hemolytic streptococci , 3 which are the most common pathogens associated with primary and secondary skin infections. Mupirocin (2% w/w) is a marketed ointment (Bactroban ® ). Clinical trials have demonstrated th -Abstract Truncated-
pharmacology & pharmacy,infectious diseases